It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
From their analysis the pooled mortality rate for patients with CKD stage 3 was 1.5 times higher (Hazard ratio 1.46, 95%CI 1.41–1.51) and 2.8 times higher for higher stages of CKD (harzard ratio 2.84, 95% 2.69–2.99) [7]. Current trends in proteinuria screening in CKD have improved but continue to vary widely, noted to be between 10 and 45% in one large health care system in the US [10]. The National Kidney Foundation and The American Society of Nephrology recently lead a task force to look at the formula to estimate GFR and have identified race as a social construct and not appropriate to be part of the estimated GFR equation. [...]primary care practitioners make up the largest portion of the US providers work force and according to the Agency for Healthcare Research and Quality, are primed to meet the goals of the triple aim of US healthcare by improving quality of care, containing costs, and improving patient experience (18). [...]identifying those at risk or with CKD and preventing complications of CKD will be essential skills for the primary care practitioner with an aging patient population.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer